Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
Twenty-two patients with hypertrophic obstructive cardiomyopathy were treated with the calcium inhibitor, verapamil, which was administered in a mean oral dose of 480 mg per day. After an average of 15 months of treatment (4 to 24 months), the QRS amplitude in the electrocardiogram was significantly...
Guardat en:
| Publicat a: | Br Heart J |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1979
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/573129/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.42.1.35 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|